Litcius/Paper detail

Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer

João Lobo, Ricardo Leão, Ad Gillis, Annette van den Berg, Lynn Anson‐Cartwright, Eshetu G. Atenafu, Kopika Kuhathaas, Peter Chung, Aaron R. Hansen, Philippe L. Bédard, Michael A.S. Jewett, Padraig Warde, Martin O’Malley, Joan Sweet, Leendert H. J. Looijenga, Robert J. Hamilton

2020European Urology Oncology66 citationsDOI

Topics & Concepts

MedicineTesticular cancerSeminomaOdds ratioConfidence intervalInternal medicineOncologyHuman chorionic gonadotropinStage (stratigraphy)BiomarkerOrchiectomyLogistic regressionCohortCancerChemotherapyBiochemistryBiologyChemistryHormonePaleontologyTesticular diseases and treatmentsSperm and Testicular FunctionGenetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer | Litcius